Literature DB >> 14699430

Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.

V Kustanovich1, J Ishii, L Crawford, M Yang, J J McGough, J T McCracken, S L Smalley, S F Nelson.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is one of the most common childhood behavioral disorders. Genetic factors contribute to the underlying liability to develop ADHD. Reports implicate variants of genes important for the synthesis, uptake, transport and receptor binding of dopamine in the etiology of ADHD, including DRD4, DAT1, DRD2, and DRD5. In the present study, we genotyped a large multiplex sample of ADHD affected children and their parents for polymorphisms in genes previously reported to be associated with ADHD. Associations were tested by the transmission disequilibrium test (TDT). The sample is sufficient to detect genotype relative risks (GRRs) for putative risk alleles. The DRD4 gene 120-bp insertion/deletion promoter polymorphism displayed a significant bias in transmission of the insertion (chi(2)=7.58, P=0.006) as suggested by an analysis of a subset of these families. The seven repeat allele of the DRD4 48-bp repeat polymorphism (DRD4.7) was not significantly associated with ADHD in the large sample in contrast to our earlier findings in a smaller subset. We replicate an association of a dinucleotide repeat polymorphism near the DRD5 gene with ADHD by showing biased nontransmission of the 146-bp allele (P=0.02) and a trend toward excess transmission of the 148-bp allele (P=0.053). No evidence for an association was found for polymorphisms in DRD2 or DAT1 in this sample. The DRD5 146-bp (DRD5.146) allele and the DRD4 240-bp (DRD4.240) allele of the promoter polymorphism emerge as the two DNA variants showing a significant association in this large sample of predominantly multiplex families with ADHD, with estimated GRRs of 1.7 and 1.37, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699430     DOI: 10.1038/sj.mp.4001466

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

Review 2.  From dopaminergic genes to psychiatric disorders.

Authors:  Janet Hoenicka; María Aragüés; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel A Jiménez-Arriero; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 3.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

4.  Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.

Authors:  Ake T Lu; Matthew N Ogdie; Marjo-Ritta Järvelin; Irma K Moilanen; Sandra K Loo; James T McCracken; James J McGough; May H Yang; Leena Peltonen; Stanley F Nelson; Rita M Cantor; Susan L Smalley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

5.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

6.  Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.

Authors:  Jun Ho Hong; In Wook Hwang; Myung Ho Lim; Ho Jang Kwon; Han Jun Jin
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

Review 7.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

8.  Personality mediation of genetic effects on Attention-Deficit/Hyperactivity Disorder.

Authors:  Michelle M Martel; Molly Nikolas; Katherine Jernigan; Karen Friderici; Joel T Nigg
Journal:  J Abnorm Child Psychol       Date:  2010-07

9.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

10.  Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.

Authors:  Naomi Lowe; Aiveen Kirley; Ziarih Hawi; Pak Sham; Harvey Wickham; Christopher J Kratochvil; Shelley D Smith; Saretta Y Lee; Florence Levy; Lindsey Kent; Fiona Middle; Luis A Rohde; Tatiana Roman; Eda Tahir; Yanke Yazgan; Philip Asherson; Jonathan Mill; Anita Thapar; Antony Payton; Richard D Todd; Timothy Stephens; Richard P Ebstein; Iris Manor; Cathy L Barr; Karen G Wigg; Richard J Sinke; Jan K Buitelaar; Susan L Smalley; Stan F Nelson; Joseph Biederman; Stephen V Faraone; Michael Gill
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.